News from Accelovance A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 13, 2015, 16:05 ET

Accelovance, Inc. expandiert globale Mitarbeiterschaft mit Unterstützung der walisischen Regierung

Accelovance, ein globales Auftragsforschungsinstitut (Contract Research Organization – CRO) mit den Schwerpunktbereichen Onkologie,...

Aug 13, 2015, 16:02 ET

Accelovance, Inc. va augmenter son effectif mondial avec une subvention du gouvernement gallois

Accelovance, Inc. (Accelovance), un organisme mondial de recherche sous contrat (CRO) qui se concentre sur le développement clinique en...

Aug 13, 2015, 04:37 ET

Accelovance, Inc. amplía su fuerza laboral mundial con una concesión del Gobierno de Gales

Accelovance, Inc. (Accelovance), una organización de investigación contractual (CRO) centrada en las áreas de oncología,...

Aug 13, 2015, 01:30 ET
Accelovance Logo

Accelovance, Inc. to Expand Global Workforce with Grant from Welsh Government

Accelovance, Inc. (Accelovance), a global contract research organization (CRO) focusing in Oncology, Vaccines, and General Medicine clinical...

Jul 08, 2015, 08:25 ET

Accelovance schließt Studienrekrutierung und Übergabe der klinischen Daten für Phase 3-Studie von Heron Therapeutics ab

Accelovance, Inc. (Accelovance), ein globales Auftragsforschungsinstitut (Contract Research Organization/CRO) mit den Schwerpunktbereichen...

Jul 07, 2015, 20:06 ET

Accelovance achève les inscriptions de patients et la délivrance de données cliniques en faveur de l'essai de phase 3 de Heron Therapeutics

Accelovance, Inc. (Accelovance), société internationale de recherche sous contrat (CRO) spécialisée en oncologie, vaccins et...

Jul 07, 2015, 16:35 ET

Accelovance completa la reclutación y entrega de datos clínicos para el ensayo de fase 3 de Heron Therapeutics

Accelovance, Inc. (Accelovance), una organización de investigación contractual (CRO) centrada en las áreas de oncología,...

Jul 07, 2015, 10:46 ET
Accelovance Logo

Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial

Accelovance, Inc. (Accelovance), a global contract research organization (CRO) focusing in Oncology, Vaccines, and General Medicine announced the...

Mar 25, 2015, 13:30 ET
Accelovance Logo.

Accelovance Nominated for 2015 Vaccine Industry Excellence (ViE) Awards

Accelovance, a therapeutically focused contract research organization (CRO), has been named a finalist for "Best Contract Research Organization" at...

Feb 05, 2015, 12:00 ET

Accelovance expande sus capacidades en Europa con la adquisición de Altair Clinical, Ltd.

Accelovance, Inc. (Accelovance), una organización de investigación contractual (CRO) alineada terapéuticamente en las áreas de...

Feb 05, 2015, 08:52 ET

Accelovance accroît ses capacités en Europe avec l'acquisition d'Altair Clinical, Ltd.

Accelovance, Inc. (Accelovance), une société de recherche sous contrat (CRO) alignée d'un point de vue thérapeutique dans les...

Feb 05, 2015, 07:51 ET

Accelovance erweitert Kapazitäten in Europa mit der Übernahme von Altair Clinical, Ltd.

Accelovance, Inc. (Accelovance), ein therapeutisch orientiertes Auftragsforschungsinstitut (Contract Research Organization / CRO) in den Bereichen...

Feb 05, 2015, 03:00 ET
Accelovance Logo

Accelovance Expands Capabilities in Europe with Acquisition of Altair Clinical, Ltd.

Accelovance, Inc. (Accelovance), a Contract Research Organization (CRO) therapeutically aligned in the areas of Oncology, Vaccines, and General...

Sep 30, 2014, 07:00 ET
Accelovance Logo.  (PRNewsFoto/Accelovance)

Former VP, Oncology, from Pfizer and Otsuka Joins Accelovance to Augment Oncology Growth

 Accelovance, Inc. (Accelovance), a contract research organization (CRO) focusing in early phase oncology, vaccines, and general medicine,...

Mar 06, 2014, 09:00 ET
Accelovance Logo.  (PRNewsFoto/Accelovance)

Accelovance Nominated for TWO 2014 Vaccine Industry Excellence (ViE) Awards

 Accelovance, a therapeutically focused clinical research organization (CRO), has been named a finalist for two Vaccine Industry Excellence...

Feb 19, 2014, 16:45 ET
Accelovance Logo.  (PRNewsFoto/Accelovance)

Accelovance Continues Expansion with Opening of Research Triangle Park, North Carolina Office

Accelovance, a therapeutically focused clinical research organization (CRO), announced today the opening of a new office in Research Triangle Park...

Jul 10, 2013, 11:18 ET

Accelovance Primed to Achieve Leadership in Oncology Clinical Trials

"Oncology Protocol Challenge" and New Appointments Underscore Commitment to Cancer Studies  This spring has seen Accelovance, a Rockville,...

Mar 26, 2013, 10:49 ET

Sixth Consecutive "Best CRO" Award Nomination for Accelovance

 Accelovance, Inc., a Maryland based contract research organization (CRO), was nominated for the 2013 ViE "Best CRO" Award for the sixth year...

Mar 06, 2013, 14:48 ET

Accelovance Expansion Continues with Acquisition of Radiant Development, the CRO Division of Radiant Research

 Accelovance, Inc. announced today the acquisition of Radiant Development, the CRO division of Radiant Research. This is the latest development...

Mar 01, 2013, 11:18 ET

Accelovance Expands Oncology Leadership with the Addition of Ralph Boccia, MD as Oncology Medical Director

 Accelovance announces the addition of Ralph Boccia, MD, FACP as the Oncology Medical Director.  The addition of Dr. Boccia is a strong...